Valley Brook Capital Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$207K Buy
530
+65
+14% +$27.5K 0.12% 114
2026
Q1
$220K Buy
+465
New +$234K 0.15% 103
2021
Q2
Sell
-300
Closed -$56K 236
2021
Q1
$56K Hold
300
0.05% 207
2020
Q4
$49K Buy
+300
New +$43.9K 0.05% 196

Other funds holding HCA

Valley Brook Capital Group's HCA Position: Q2 2026 in Review

Valley Brook Capital Group increased its HCA Healthcare (HCA) stake by 14% in Q2 2026, buying an estimated $27.5K and bringing the position to 530 shares worth $207K. The position accounts for 0.12% of the portfolio, ranked #114.

Valley Brook Capital Group first reported a position in HCA in Q4 2020 and has held it in 4 quarters since. The position peaked at $220K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Valley Brook Capital Group held 530 shares of HCA Healthcare worth $207K as of Q2 2026.
  • Valley Brook Capital Group bought 65 HCA Healthcare shares in Q2 2026, an estimated $27.5K.
  • HCA Healthcare made up 0.12% of Valley Brook Capital Group's portfolio in Q2 2026, its #114 holding.
  • Valley Brook Capital Group first reported a position in HCA Healthcare in Q4 2020 and has held it in 4 quarters since.
  • Valley Brook Capital Group's HCA Healthcare position peaked at $220K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Valley Brook Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.